TransMedics Group, Inc. Common Stock(TMDX)
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
- 52-Week Range
- $60.10 – $156.00
- YTD
- -29.56%
- IV Rank (30D)
- 31.79
- Straddle Price
- $8.97
- P/C Vol Ratio
- 0.32
- Market Cap
- $3.0B
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 5.00% |
| Beta vs SPY | 1.26 |
| Cost of Equity (CAPM) | 11.93% (VRP-adj) |
| WACC | 10.18% |
| Volatility Risk Premium | +46.1pp (IV − HV30), ERP adj +50bps |
| Effective Tax Rate | 21.0% |
| Rev. Growth (YoY, DCF input) | +30.0% |
| DCF Horizon | 12 years explicit + fade |
| Forward Tilt (NTM/TTM) | ×1.10 (applied to P/E, EV/EBITDA, P/S) |
| Free Cash Flow (TTM) | $0.1B |
| Return on Equity (TTM) | 29.3% |
| Book / Price | 15.1% |
| Gross Margin (TTM) | 58.7% |
| FCF Margin (TTM) | 11.8% |
| Debt / Equity | 1.62 |
| Quality Score | 4/6 — high quality (12y DCF) |
| Market-Implied Growth | +23.2% (reverse-DCF on current price) |
| SMA 50 | $82.90 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $88.18 |
| Bollinger Width / SMA20 | 18.6% (drives anchor stability) |
| Net Debt | $0.4B |
| Market Cap | $3B |
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | $136.07 | 29% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | $139.99 | 13% | median 33.0× · 3 peers |
| Peer EV/EBITDA | $81.54 | 13% | median 27.7× · 4 peers |
| Peer P/B | $118.16 | 3% | median 9.0× · 6 peers |
| Peer P/S | $189.18 | 9% | median 10.2× · 6 peers |
| Market Anchor (SMA50) | $82.90 | 33% | stability 57% (BB-width) |
| Options Expected (B-L 30d) | n/a | 0% |
- Industry (SIC)
- ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS (3845)
- Exchange
- XNAS
- Market Cap
- $3.0B
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-…
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
| Month | Avg Return | Years of Data |
|---|---|---|
| Jan | +1.16% | 6 |
| Feb | +19.69% | 6 |
| Mar | -0.70% | 6 |
| Apr | +0.42% | 6 |
| May | +12.00% | 6 |
| Jun | +11.94% | 6 |
| Jul | +1.38% | 6 |
| Aug | +3.32% | 6 |
| Sep | -5.12% | 6 |
| Oct | -6.49% | 5 |
| Nov | +22.33% | 5 |
| Dec | -9.09% | 5 |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
LLM Stock Analysis Report
Executive Summary Overall Assessment: NEUTRAL (Confidence Level: 6/10) Key Drivers: Recent news sentiment, market context, and technical signals Primary Risks: High volatility, potential reversal of recent gains Investment Thesis: TMDX presents a mixed signal, with both bullish and bearish arguments. The stock's high volatility may lead to significant moves, but the current trend is trending sideways. Recent News Sentiment Impact: Positive news headlines have been somewhat offset by negative sentiment from short interest data.
Technical Analysis Trend Direction:
- Short-term (1-4 weeks): Sideways
- Medium-term (1-3 months): Uptrend
- Long-term (3-12 months): Bullish
Support/Resistance Levels:
- Upper Bollinger Band: $79.05
- Lower Bollinger Band: $65.78
- Trend Line Support: $72.42 (SMA 20)
- Trend Line Resistance: $82.17 (SMA 50)
Momentum Signals:
- RSI Interpretation: Neutral (53.18) with no clear buy/sell signal
- MACD Signal: Bearish (histogram -2.04), indicating a potential short-term decline
Volume Analysis:
- Volume SMA 20: 1061314.65, suggesting normal trading volume
- On-Balance Volume (OBV): -40268068.84, reflecting net selling pressure
- Volume Rate of Change: -87.25%, indicating decreased trading interest
News & Sentiment Analysis Recent Headlines Summary:
- Positive news: Growth stock worth $5,000, TransMedics' 104% year-over-year gain
- Negative news: Short interest in Avis Budget and MARA soars above 40%
- Neutral news: Joby Aviation stock's performance
Sentiment Assessment: Mixed sentiment with a slight tilt towards positive news (4/6 positive headlines)
Catalyst Identification:
- Upcoming events: None reported
- Earnings dates: Not available
- Regulatory changes: None reported
Market Narrative:
- News sentiment aligns somewhat with the technical signals, but the overall trend is still neutral.
Risk & Volatility Assessment Beta Interpretation: High risk (1.28) relative to the market
Volatility Regime: High volatility - stock moves more than the market
Options Market Signals:
- IV Rank: 77.8% (High)
- Put/Call Volume Ratio: 0.34 (Bullish sentiment)
Downside Protection:
- Support levels: SMA 20 ($72.42), Lower Bollinger Band ($65.78)
- Risk management considerations: Stop-loss levels and position sizing
Market Context & Positioning Sector Performance: TMDX is performing relatively well within its sector Institutional Activity: Increased short interest suggests institutional selling pressure Correlation Analysis: Stock moves more than the market (R-squared interpretation)
Relative Valuation: TMDX is positioned within a trading range, with no clear uptrend or downtrend.
Key Levels & Action Items Critical Price Levels:
- Support: SMA 20 ($72.42), Lower Bollinger Band ($65.78)
- Resistance: Upper Bollinger Band ($79.05)
Breakout/Breakdown Levels:
- Technical levels that could trigger significant moves: $77.30 (current price) and $82.17 (SMA 50)
Time-Sensitive Catalysts:
- Earnings dates: Not available
- Product launches: None reported
- Regulatory changes: None reported
Risk Management:
- Stop-loss levels: Consider setting stop-loss at SMA 20 ($72.42) or Lower Bollinger Band ($65.78)
- Position sizing: Manage position size considering high volatility and market context
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2024-10-28 | After-Close | 30.81% | 29.90% | 0.97x | Within |
| 2025-02-27 | After-Close | 24.47% | 1.02% | 0.04x | Within |
| 2025-05-08 | After-Close | 19.30% | 20.37% | 1.06x | Exceeded |
| 2025-07-30 | After-Close | 19.55% | 10.46% | 0.54x | Within |
| 2025-10-29 | After-Close | 24.12% | 1.09% | 0.05x | Within |
| 2026-02-24 | After-Close | 17.56% | 3.39% | 0.19x | Within |
| 2026-05-05 | After-Close | 16.01% | 22.80% | 1.42x | Exceeded |
| 2026-08-04 | After-Close | 18.58% | 5.28% | 0.28x | Within |
- IV Rank (30D)
- 31.79
- IV Rank (7D)
- 8.01
- Avg IV
- 87.4%
- Straddle (30D)
- $8.97
- Straddle (7D)
- $4.68
- P/C Volume
- 0.32
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Enter a ticker to render the implied volatility surface.
Enter a ticker to render the implied volatility smile.
- Beta (1Y vs SPY)
- 1.14
- Correlation (SPY)
- 25.8%
- R²
- 0.07
- Ann. Volatility
- 57.0%
- SPY Volatility
- 12.9%
Above average volatility - stock moves with market amplification
Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian | $44.18M | 35.15% | 2026-06-30 |
| 2 | CITADEL ADVISORS LLC Custodian | $27.17M | 21.62% | 2026-06-30 |
| 3 | JANE STREET GROUP, LLC Custodian | $23.64M | 18.81% | 2026-06-30 |
| 4 | IMC-Chicago, LLC Custodian | $10.18M | 8.10% | 2026-06-30 |
| 5 | WOLVERINE TRADING, LLC Custodian | $8.57M | 6.82% | 2025-09-30 |
| 6 | SIMPLEX TRADING, LLC Custodian | $2.89M | 2.30% | 2026-06-30 |
| 7 | Cubist Systematic Strategies, LLC | $2.13M | 1.70% | 2025-09-30 |
| 8 | TUDOR INVESTMENT CORP ET AL | $1.38M | 1.10% | 2026-06-30 |
| 9 | GROUP ONE TRADING LLC Custodian | $983.02K | 0.78% | 2026-06-30 |
| 10 | MILLENNIUM MANAGEMENT LLC Custodian | $976.37K | 0.78% | 2026-06-30 |
| 11 | Walleye Capital LLC | $737.26K | 0.59% | 2026-06-30 |
| 12 | Perigon Wealth Management, LLC | $697.41K | 0.55% | 2026-06-30 |
| 13 | Point72 Asset Management, L.P. | $511.43K | 0.41% | 2026-06-30 |
| 14 | Walleye Trading LLC | $491.51K | 0.39% | 2026-06-30 |
| 15 | D. E. Shaw & Co., Inc. Custodian | $332.10K | 0.26% | 2026-06-30 |
| 16 | CSS LLC/IL | $265.68K | 0.21% | 2026-06-30 |
| 17 | Squarepoint Ops LLC | $259.04K | 0.21% | 2026-06-30 |
| 18 | Carmel Capital Partners, LLC | $132.84K | 0.11% | 2026-06-30 |
| 19 | Cerity Partners LLC Custodian | $66.42K | 0.05% | 2026-06-30 |
| 20 | UBS Group AG Custodian | $66.42K | 0.05% | 2026-06-30 |
| 21 | Advisory Services Network, LLC Custodian | $6.64K | <0.01% | 2026-06-30 |
| 22 | RAYMOND JAMES FINANCIAL INC Custodian | $5.00K | <0.01% | 2026-06-30 |
| 23 | OSAIC HOLDINGS, INC. Custodian | $1.25K | <0.01% | 2026-06-30 |
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian | $34.64M | 24.75% | 2026-06-30 |
| 2 | Tidal Investments LLC | $33.21M | 23.72% | 2026-06-30 |
| 3 | CITADEL ADVISORS LLC Custodian | $29.84M | 21.32% | 2026-06-30 |
| 4 | JANE STREET GROUP, LLC Custodian | $17.23M | 12.31% | 2026-06-30 |
| 5 | IMC-Chicago, LLC Custodian | $9.16M | 6.54% | 2026-06-30 |
| 6 | WOLVERINE TRADING, LLC Custodian | $6.90M | 4.93% | 2025-09-30 |
| 7 | Cubist Systematic Strategies, LLC | $2.33M | 1.67% | 2025-09-30 |
| 8 | SIMPLEX TRADING, LLC Custodian | $1.73M | 1.24% | 2026-06-30 |
| 9 | 683 Capital Management, LLC | $1.33M | 0.95% | 2026-06-30 |
| 10 | GROUP ONE TRADING LLC Custodian | $1.04M | 0.74% | 2026-06-30 |
| 11 | Point72 Asset Management, L.P. | $763.83K | 0.55% | 2026-06-30 |
| 12 | WOLVERINE ASSET MANAGEMENT LLC | $637.63K | 0.46% | 2026-06-30 |
| 13 | TUDOR INVESTMENT CORP ET AL | $571.21K | 0.41% | 2026-06-30 |
| 14 | Walleye Capital LLC | $245.75K | 0.18% | 2026-06-30 |
| 15 | CSS LLC/IL | $212.54K | 0.15% | 2026-06-30 |
| 16 | Walleye Trading LLC | $126.20K | 0.09% | 2026-06-30 |
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-09-14 | David Weill | Director | Buy (P) | +1,336 | $81.63 | $109.1K | EDGAR |
| 2026-08-17 | JAMES R TOBIN | Director | Gift (G) | −18,000 | — | EDGAR | |
| 2026-07-14 | Nicholas Corcoran | See remarks | Award (A) | +11,727 | — | EDGAR | |
| 2026-07-14 | Gerardo Hernandez | Chief Financial Officer | Award (A) | +17,246 | — | EDGAR | |
| 2026-07-14 | Waleed H Hassanein | President & CEO | Award (A) | +49,669 | — | EDGAR | |
| 2026-06-17 | Thomas J. Gunderson | Director | Mixed | +9,661 | $26.46 | -$679.8K | EDGAR |
| 2026-05-22 | MERILEE RAINES | Director | Award (A) | +2,922 | — | EDGAR | |
| 2026-05-22 | Edward M Basile | Director | Award (A) | +2,922 | — | EDGAR | |
| 2026-05-22 | David Weill | Director | Award (A) | +2,922 | — | EDGAR | |
| 2026-05-22 | JAMES R TOBIN | Director | Award (A) | +2,922 | — | EDGAR | |
| 2026-05-22 | Stephanie Lovell | Director | Award (A) | +2,922 | — | EDGAR | |
| 2026-05-22 | Thomas J. Gunderson | Director | Award (A) | +2,922 | — | EDGAR | |
| 2026-05-22 | Edwin Kania | Director | Award (A) | +2,922 | — | EDGAR | |
| 2026-05-21 | Matthew S. Forsyth | See Remarks | Award (A) | +15,409 | — | EDGAR | |
| 2026-03-06 | Stephanie Lovell | Director | Sell (S) | −1,193 | $149.62 | -$178.5K | EDGAR |
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | ABRAMS CAPITAL, LLC | 10%+ Owner | 3,499,859 | $302.46M | $0 | 1 | 2019-05-06 |
| 2 | David C Abrams | 10%+ Owner | 3,411,376 | $294.81M | -$199.71M | 1 | 2021-02-10 |
| 3 | Biotechnology PBC Lung | 10%+ Owner | 2,053,240 | $177.44M | -$18.75M | 2 | 2019-12-10 |
| 4 | Waleed H Hassanein | President & CEO | 516,102 | $44.60M | -$45.42M | 52 | 2026-07-14 |
| 5 | Edwin Kania | Director | 309,874 | $26.78M | $2.79M | 12 | 2026-05-22 |
| 6 | Flagship Ventures 2007 General Partner LLC | 10%+ Owner | 214,285 | $18.52M | $0 | 1 | 2019-05-06 |
| 7 | JAMES R TOBIN | Director | 162,127 | $14.01M | -$14.29M | 21 | 2026-08-17 |
| 8 | Nicholas Corcoran | See remarks | 41,558 | $3.59M | -$2.59M | 7 | 2026-07-14 |
| 9 | Tamer I Khayal | Chief Commercial Officer | 36,042 | $3.11M | -$37.21M | 54 | 2025-03-05 |
| 10 | Gerardo Hernandez | Chief Financial Officer | 31,935 | $2.76M | -$1.25M | 5 | 2026-07-14 |
What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. Amendments (Form 144/A) and post-cancellation refilings can inflate this if you sum naively; the rollup above excludes filings with zero stated value.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2026-06-15 | THOMAS GUNDERSON | Director | 9,624 | $722.4K | 2026-06-15 | Morgan Stanley Smith Barney LLC … | — | EDGAR |
| 2026-03-04 | GERARDO P HERNANDEZ | Officer | 7,236 | $1.07M | 2026-03-04 | Morgan Stanley Smith Barney LLC … | — | EDGAR |
| 2026-03-04 | STEPHANIE LOVELL | Director | 1,193 | $178.5K | 2026-03-04 | Morgan Stanley Smith Barney LLC … | — | EDGAR |
| 2026-03-04 | DAVID WEILL | Director | 3,571 | $524.3K | 2026-03-04 | Morgan Stanley Smith Barney LLC … | — | EDGAR |
| 2025-12-03 | DAVID WEILL | Director | 5,000 | $693.2K | 2025-12-03 | Morgan Stanley Smith Barney LLC … | — | EDGAR |
| 2025-11-25 | ANIL P RANGANATH | Officer | 3,000 | $435.7K | 2025-11-25 | Morgan Stanley Smith Barney LLC … | — | EDGAR |
| 2025-10-29 | EDWARD BASILE | Director | 4,142 | $540.3K | 2025-10-29 | Morgan Stanley Smith Barney LLC … | 10b5-1 | EDGAR |
| 2025-08-04 | EDWARD BASILE | Director | 4,143 | $520.0K | 2025-08-04 | Morgan Stanley Smith Barney LLC … | 10b5-1 | EDGAR |
| 2025-05-27 | EDWARD BASILE | Director | 5,000 | $632.2K | 2025-05-27 | Morgan Stanley Smith Barney LLC … | 10b5-1 | EDGAR |
| 2025-05-23 | DAVID WEILL | Director | 732 | $90.7K | 2025-05-23 | Morgan Stanley Smith Barney LLC … | — | EDGAR |
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
| P/E Ratio | 22.4 |
| P/B Ratio | 5.8 |
| P/S Ratio | 4.5 |
| EV/EBITDA | 28.8 |
| TTM Revenue | $0.7B |
| TTM Net Income | $0.2B |
| TTM EPS | $3.86 |
| ROE | 29.3% |
| Debt/Equity | 1.66 |